The Recall Desk
HighFDA (Devices)·Z-1636-2026·Announced 2026-04-01

[pending] Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin

Pending LLM rewrite. Source: FDA_DEVICE Z-1636-2026.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.

The recalled product

Product
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current i
Manufacturer
Tandem Diabetes Care, Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Version 7.8.1/ UDI: (01)008500066132625

Distribution

Distribution scope not specified by the agency.